baber/WOPTO huggingface dataset:
Patent CA-2698163-A1 (CA)
Inventor: SHIN NAMHEE
IPC: D21C3/00
Filed: 2010-03-30
Abstract: A continuous process for producing a chemical grade pulp, the process comprising the steps of: (a) steaming lignocellulosic material for a first period of time between 1 and 60 minutes; (b) after steaming, impregnating the steamed lignocellulosic material in an impregnation vessel with green liquor for a second period of time up to 5 minutes and at a temperature between 110°C  and 150°C; and (c) after impregnation, continuously cooking the lignocellulosic material in a digester to produce a chemical grade pulp.
Patent CA-2698929-A1 (CA)
Inventor: CID-NUNEZ JOSE MARIA
IPC: C07D405/14
Filed: 2008-09-12
Abstract: The present invention relates to novel compounds, in particular novel pyridinone derivatives according to Formula (I) wherein all radicals are as defined in the application and claims. The compounds according to the invention are positive allosteric modulators of metabotropic receptors -subtype 2("mGluR2") which are useful for the treatment or prevention of neurological and psychiatric disorders associated with glutamate dysfunction and diseases in which the mGluR2 subtype of metabotropic receptors is involved. In particular, such diseases are central nervous system disorders selected from the group of anxiety, schizophrenia, migraine, depression, and epilepsy. The invention is also directed to pharmaceutical compositions and processes to prepare such compounds and compositions, as well as to the use of such compounds for the prevention and treatment of such diseases in which mGluR2 is involved.
Patent CA-2704362-A1 (CA)
Title: Fuel cell system with low-efficiency operation point
Inventor: MANABE KOTA
IPC: H01M8/04
Filed: 2006-12-05
Abstract: There is disclosed a fuel cell system capable of stably operating auxiliary devices driven at a high voltage and the like, even in a case where a poisoned electrode catalyst is recovered or a fuel cell is warmed up. On detecting that the electrode catalyst is poisoned, a controller derives a target operation point which is sufficient for recovering an activity of the poisoned electrode catalyst. Then, shift of the operation point from a usual operation point to a low-efficiency operation point is realized so that an output power is held to be constant.
Patent CA-2707828-A1 (CA)
Inventor: SAGISAKA MINAKO
IPC: A61F13/496
Filed: 2008-08-15
Abstract: The present invention provides a disposable pants-type wearing article improved so as to eliminate a possibility that elastic members attached to peripheral edges of respective leg-openings might irritate the wearer's skin.     The disposable pants-type wearing article has a band-like elastic member 30 having a width dimension in a range of 5 to 60mm and extending along peripheral edges of leg-openings 12 so as to go half around each of the leg-openings 12. The elastic member 30 comprises opposite end segments 32 each lying in the uppermost zone of the leg-opening 12, a middle segment 31 lying in the lowermost zone of the leg-opening 12 and extending across a crotch region 6 and intermediate segments 34 each extending between the associated end segment 32 and the middle segment 31 wherein the intermediate segments 34 are not bonded to sheet material constituting the wearing article 1.
Patent CA-2707903-A1 (CA)
Title: Poudre a base de fer pour la metallurgie des poudres
Inventor: ONO TOMOSHIGE
IPC: B22F1/16
Filed: 2007-12-13
Abstract: L'invention porte sur une poudre à base de fer pour métallurgie des poudres, laquelle poudre peut être moulée tout en garantissant une fluidité élevée, un remplissage uniforme dans une cavité mince et une force de retrait élevée qui peut être obtenue par l'adhésion de particules améliorant la fluidité, par l'intermédiaire d'un liant, sur la surface de la poudre de fer.
Patent CA-2709202-A1 (CA)
Title: Fused pyridine, pyrimidine and triazine compounds as cell cycle inhibitors
Inventor: CONNORS RICHARD V
IPC: C07D487/04
Filed: 2008-12-18
Abstract: Compounds, pharmaceutical compositions and methods are provided that are useful in the treatment of CDK4--mediated disorders, such as cancer. The subject compounds are fused pyridine, pyrimide and triazine derivatives.
Patent CA-2709236-A1 (CA)
Inventor: DABRE RAHUL
IPC: A61K9/58
Filed: 2008-09-16
Abstract: The invention relates to pharmaceutical compositions of rhein or diacerein, or salts or esters or prodrugs thereof which are bioequivalent to a 50 mg diacerein formulation marketed under the trade name Art 50?. The compositions exhibit no variability in fed and fasted state conditions. The compositions also result in significant reduction in side effects such as, soft stools as compared to Art 50?. The invention also relates to the methods for preparing such compositions.
Patent CA-2712132-A1 (CA)
Inventor: MIRICA VIOREL
IPC: F21S8/00
Filed: 2010-08-03
Abstract: A sign-type lighting fixture assembly is provided herein. The assembly includes an illuminating lighting fixture, a canopy, and a canopy lock. The lighting fixture has a housing with a perimetrical wall. The perimetrical wall includes a fixture opening therein. The canopy secures the lighting fixture to the canopy. The canopy has a canopy opening for passage of electrical wires. The canopy further includes a pair of inwardly deflectable fingers for insertion into the fixture opening for resilient securement to the perimetrical wall of the lighting fixture.  The canopy lock is configured to be inserted into the canopy opening. The canopy lock is disposed between the pair of deflectable fingers of the canopy to prevent inward deflection of the fingers of the canopy to prevent removal from the lighting fixture.
Patent CA-2714808-A1 (CA)
Title: Selective estrogen receptor modulator compositions and methods for treatment of disease
Inventor: SCANLAN THOMAS S
IPC: A61K31/167
Filed: 2008-11-07
Abstract: The present disclosure concerns a new class of selective estrogen receptor modulators (SERMs). The disclosure also includes the identification of a previously unknown membrane associated estrogen receptor. Methods for making and using the disclosed SERMs are disclosed, including pharmaceutical formulations of the disclosed novel compounds in useful compositions.
Patent CA-2715464-A1 (CA)
Inventor: GILBERT JAMES A
IPC: A61B18/12
Filed: 2010-09-23
Abstract: An electrosurgical generator is disclosed. The generator includes a power supply operable to generate a DC voltage and a multi-pole, phase-shifted, pulse-width and/or frequency modulated RF output stage coupled to the power supply. The RF output stage includes a plurality of dual-pole circuits, each of the plurality of dual-pole circuits including first and second pairs of switching components. The generator also includes a controller configured to drive the first and second pairs of switching components of each of the plurality of dual-pole circuits at a predetermined phase-shifted frequency.
Patent CA-2717644-A1 (CA)
Inventor: CHIN TOM
IPC: H04W56/00
Filed: 2009-03-03
Abstract: A method for measuring round-trip delay at a mobile station may include determining a first time difference between two different types of frames at a base station. The method may also include determining a second time difference between the two different types of frames at a mobile station. The method may also include calculating the round-trip delay based on the first time difference and the second time difference.
Patent CA-2719152-A1 (CA)
Title: Methode de detection et/ou de titrage in vitro d'un agent transmissible non conventionnel
Inventor: FLAN BENOIT
IPC: G01N33/68
Filed: 2009-03-25
Abstract: L'invention concerne une méthode in vitro de détection et/ou titrage in vitro d'un agent transmissible non conventionnel (ATNC) ou d'une protéine de conformation pathologique, marqueur de l'infectiosité liée à l'ATNC, dans un échantillon, comprenant : la réplication ou la propagation dans des cellules en culture de l'ATNC présent dans l'échantillon, puis l'incubation répétée avec un substrat permettant l'amplification de l'ATNC ou de la protéine de conformation pathologique, conformère non-pathologique de l'ATNC, avant la détermination de la présence et/ou de la quantité de l'ATNC ou de la protéine de conformation pathologique dans l'échantillon.
Patent CA-2721325-A1 (CA)
Inventor: STASZ PETER
IPC: A61B5/08
Filed: 2009-04-09
Abstract: An apparatus or method can be configured to receive first information indicative of respiratory effort of a subject from a first piezoelectric film sensor and second information indicative of respiratory effort of the subject from a second piezoelectric film sensor, and to process the received first and second information to produce an electronic signal output indicative of respiratory effort of the subject, the processing including averaging the received first information using a first differential amplifier and signal integrator with resistive reset to reduce differential noise and to attenuate common-mode noise, and averaging the received second information using a second differential amplifier and signal integrator with resistive reset to reduce differential noise and to attenuate common-mode noise.
Patent CA-2723909-A1 (CA)
Inventor: BULL RICHARD JAMES
IPC: A61K31/428
Filed: 2009-05-12
Abstract: The invention provides a pharmaceutical product, kit or composition comprising a first active ingredient which is a selected muscarinic receptor antagonist, and a second active ingredient which is a .beta.2-adrenoceptor agonist, of use in the treatment of respiratory diseases such as chronic obstructive pulmonary disease and asthma.
Patent CA-2727260-A1 (CA)
Title: Interconnexion en pont de raccordement a travers du silicium
Inventor: CHANDRASEKARAN ARVIND
IPC: H01L25/065
Filed: 2009-06-24
Abstract: La présente invention concerne un système dinterconnexion en pont de circuit intégré qui comprend une première puce et une seconde puce formées dans une configuration côte à côte et interconnectées électriquement entre elles par une puce en pont. La puce en pont comprend des trous dinterconnexion à travers du silicium (TSV) pour connecter des lignes dinterconnexion conductrices sur la puce en pont à la première puce et à la seconde puce. Des circuits actifs différents des lignes dinterconnexion peuvent être formés sur la puce en pont. La ou les puces supplémentaires au moins peuvent être empilées sur la puce en pont et interconnectées à celle-ci.
Patent CA-2728263-A1 (CA)
Inventor: WIESENDANGER MARKUS
IPC: G01B7/14
Filed: 2011-01-13
Abstract: The invention refers to an inspection vehicle (24) for inspecting an air gap (14) between the rotor (11) and the stator (12) of a generator (10), which inspection vehicle (24) has drive elements (25, 27) for the independent progressive movement in the air gap (14). A particularly compact construction and flexible application is achieved by the drive elements (26, 27) being formed as elongated, flexionally elastic, torsionally rigid, magnetic rolls.
Patent CA-2729735-A1 (CA)
Inventor: ESSEGHIR MOHAMED
IPC: C08L23/04
Filed: 2009-06-29
Abstract: The present invention is a moisture crosslinkable composition. It may be (i) a blend of a nonpolar polyolefin and a second highly polar or amorphous polyolefin or (ii) a copolymer of a nonpolar polyolefin and the second polar or amorphous polyolefin. The present invention is useful for the preparation of moisture-cured wires, cables, film, pipe, hot melt adhesives, and other extruded or injection molded articles. The present invention is also useful in the preparation of media for fast transport of se-lective species, including film membranes.
Patent CA-2730212-A1 (CA)
Inventor: YANCEY JAMES
IPC: B27B17/02
Filed: 2009-05-22
Abstract: Embodiments provide various saw chain links which may be combined to form a utility saw chain. In various other embodiments, cutting system fixtures are disclosed which may facilitate the cutting of pipes and other materials from an axis point.
Patent CA-2732150-A1 (CA)
Title: System and method for enhanced maneuverability
Inventor: BLUM YORAM
IPC: A61B1/04
Filed: 2009-07-30
Abstract: The present invention relates to an imaging apparatus comprising an elongated carrier adapted to be inserted through a proximal opening of a gastrointestinal (GI) tract lumen; a piston head, coupled to a distal portion of the carrier, and configured to: be inflated so as to form and maintain a pressure seal with a wall of the GI tract lumen, and be advanced distally through the GI tract in response to pressure from a fluid pressure source; a distal balloon coupled to the carrier distal to the piston head and configured and operable to be inflated so as to dilate the lumen thereby creating a working space; and a control unit, configured and operable to control simultaneously a pressure level within the piston head and a pressure level within the distal balloon. The control comprises maintaining a constant level of pressure within the piston head thereby maintaining said pressure seal and cyclically modulating the level of pressure within the distal balloon facilitating the distal advancement of the piston head within the GI tract lumen.
Patent CA-2736013-A1 (CA)
Title: Storage system
Inventor: MAEKIRANTA JARKKO
IPC: G06Q10/00
Filed: 2008-09-03
Abstract: A storage system (500) comprises a storage unit (100), wherein said storage unit (100) has sites (S1a, S1b) for accommodating two or more of said objects (G1), said storage unit (100) further comprising one or more capacitive proximity sensors (50) arranged to detect the presence of said objects (G1) in the vicinity of said sites (S1a, S1b). The storage unit may be e.g. a shelving in a retail store. The filling ratio (N/Nmax) or the number (N) of objects on the shelves (90) may be monitored in real time. Consequently, out-of-shelf situations may be effectively avoided.
Patent CA-2738067-A1 (CA)
Inventor: YU CHEUNG HOI ALBERT
IPC: G01N33/53
Filed: 2009-10-09
Abstract: A method for detecting a target analyte associated with nano-sized gold- and /or silver-containing detecting labels m a microarray of samples, wherein the labels indicate presence or absence of a target analyte in a sample, comprises (i) sequentially illuminating at least two sample groups with at least two different monochromatic lights, said sample groups including (a) a first sample group containing at least one sample potentially containing the target analyte, and (b) a second sample group serving as positive control or negative control, (n) detecting intensity of light reflected, absorbed or emitted from each of said sample groups when illuminated with each of the monochromatic lights, (ni) recording groups of values associated with the light intensity reflected, absorbed or emitted from the sample groups, with each group of values associated with each of the monochromatic lights for each of the sample groups, (iv) comparing the groups of values associated with said sample groups and each of said monochromatic lights, and (v) determining the presence or absence of the target analyte based on the comparison m step (iv), wherein said monochromatic lights include at least a blue monochromatic light or a monochromatic light with a frequency in the range of 10nm to 100nm Apparatus for performing such method is also disclosed.
Patent CA-2738311-A1 (CA)
Inventor: HORNER GLENN A
IPC: A61B18/14
Filed: 2011-04-28
Abstract: An end effector assembly for use with an electrosurgical instrument is provided. The end effector assembly has a pair of opposing jaw members. One or more of the jaw members includes a support base, an electrical jaw lead, and a sealing plate coupled to the electrical jaw lead. The sealing plate has a stainless steel layer and one or more piezoelectric sensors. The jaw member also includes an insulative plate disposed between the support base and the sealing plate.
Patent CA-2742302-A1 (CA)
Title: Antiviral supplement formulations
Inventor: PHILLIPS KENNETH E
IPC: A01N25/00
Filed: 2009-10-30
Abstract: The disclosure provides an oral antiviral supplement composition comprising a lysine, an ascorbic compound, a flavonoid glycoside, a threonine, and a pyridoxine. The disclosure also provides a method of reducing viral replication in a cell comprising treating a virus-infected cell with a composition of the disclosure. The disclosure further provides a method for the treatment and prophylaxis of a viral infection in a patient comprising administering a composition of the disclosure.
Patent CA-2744822-A1 (CA)
Inventor: ALI SHIROOK M
IPC: H01Q5/10
Filed: 2009-11-25
Abstract: An antenna assembly is formed on a rectangular polyhedron support that has two sections projecting away from opposite sides of an electrically non-conductive substrate. An electrically conductive stripe wraps around the support and comprises a plurality of segments on different surfaces of the support. A  conductive patch is located on two surfaces of the support to provide impedance matching between the antenna and a radio frequency circuit.  By placing sections of the antenna assembly on both sides of the substrate and wrapping the conductive stripe around those sections, the space required to accommodate the antenna assembly within a housing of a communication device is reduced, as compared to some prior antenna designs.
Patent CA-2745958-A1 (CA)
Inventor: BABICH JOHN W
IPC: A61K51/08
Filed: 2009-12-04
Abstract: A compound that recognizes and binds to the CA-IX protein has Formula I, II, III, or N. The compounds may include a radioactive element for radioimaging or therapeutic applications. Thus, pharmaceutical compositions may be prepared with one or more of the compounds of Formula (I), (II), (III), or (IV).
Patent CA-2746514-A1 (CA)
Title: Gnaq targeted dsrna compositions and methods for inhibiting expression
Inventor: GOLLOB JARED
IPC: A61K31/713
Filed: 2009-12-10
Abstract: The invention relates to a double-stranded ribonucleic acid (dsRNA) targeting a G-alpha q subunit (GNAQ) of a heterotrimeric G gene, and methods of using the dsRNA to inhibit expression of GNAQ.
Patent CA-2748561-A1 (CA)
Inventor: KITAGUCHI NOBUYA
IPC: A61K35/14
Filed: 2009-12-21
Abstract: An object is to provide a material capable of removing A.beta. from a body fluid efficiently and use of the material, which are developed for the purpose of establishing a therapeutic or preventive method for Alzheimer's disease. Provided is an amyloid .beta. protein remover, containing a carrier made of any one material selected from the group consisting of cellulose, silica, polyvinyl alcohol, and activated carbon, wherein the carrier does not have an alkyl chain on the surface thereof or has an alkyl chain having 1 to 18 carbon atoms on the surface thereof.
Patent CA-2749333-A1 (CA)
Inventor: BAIN JERALD
IPC: A61K35/57
Filed: 2009-01-09
Abstract: Fertilized egg isolate, methods for preparing the fertilized egg isolate and uses thereof for treating mental health disorders and disease or conditions mediated by or associated with one or more glutamate receptors or by the neurokinin 2 (NK2) receptor.
Patent CA-2749674-A1 (CA)
Inventor: FOLTING ALLAN
IPC: G06F9/44
Filed: 2010-02-04
Abstract: Technologies are described herein for allowing a user of an interactive summary table to specify multi-condition data filters to modify the data displayed in the summary table. A user interface is displayed to the user that allows the user to specify a multi-condition data filter. The specification of the multi-condition data filter includes a set of filter conditions connected by logical operators. One or more filter expressions are parsed from the specification of the multi-condition data filter based on the filter conditions and the logical operators, and the filter expressions are applied to the summary data from which the summary table is displayed.
Patent CA-2752603-A1 (CA)
Inventor: MICHELS MARTIN
IPC: A61K31/4353
Filed: 2010-02-05
Abstract: This invention relates to novel bi- and tricyclic indazole-substituted 1,4-dihydropyridine derivatives having protein tyrosine kinase inhibitory activity, to a process for the manufacture thereof and to the use thereof for the treatment of c-Met-mediated diseases or c-Met-mediated conditions, particularly cancer and other proliferative disorders.
Patent CA-2755537-A1 (CA)
Inventor: MITCHELL BRADLEY J
IPC: H04B1/02
Filed: 2011-10-19
Abstract: An energy harvesting device is disclosed that includes a thermoelectric device adapted to produce electricity according to a Seebeck effect when a thermal gradient is imposed across first and second major surfaces thereof, a housing enclosing a phase change material that is disposed for thermal communication with the first major surface of the thermoelectric device, and a radio transmitter electrically coupled to the thermoelectric device, the radio transmitter capable of transmitting wireless signals. In another aspect, the housing includes a conductive fin therein to provide more uniform distribution of heat to the phase change material.
Patent CA-2759293-A1 (CA)
Inventor: HODJAT BABAK
IPC: G06F15/173
Filed: 2010-04-28
Abstract: A server computer and a multitude of client computers form a network computing system that is scalable and adapted to continue to evaluate the performance characteristics of a number of genes generated using a software application. Each client computer continues to periodi-cally receive data associated with the stored genes stored in its memory.  Using this data, the client computers evaluate the performance characteris-tic of their genes by comparing a solution provided by the gene with the periodically received data associated with that gene. Accordingly, the per-formance characteristic of each gene may be updated and varied with each periodically received data. The performance characteristic of a gene de-fines its fitness. The genes may be virtual asset traders that recommend trading options. The genes may be assigned initially to different classes to improve convergence but may later be decided to merge with genes of oth-er classes to improve diversity.
Patent CA-2762530-A1 (CA)
Title: Degradation-stabilised, biocompatible collagen matrices
Inventor: MALESSA RALF
IPC: C08J3/24
Filed: 2011-12-21
Abstract: The present invention relates to degradation-stabilised, biocompatible collagen matrices which are distinguished in particular by the fact that they contain soluble collagen and peptide constituents, to processes for the preparation of such collagen matrices, which processes include in particular chemical crosslinking with an epoxy-functional crosslinking agent, and to the use of the collagen matrices according to the invention as a cosmetic or pharmaceutical agent, in particular for topical use, and as a wound treatment agent, as an implant or as a haemostatic agent in humans or animals, and as a scaffold for cell population in the biotechnology, basic research and tissue engineering field.
Patent CA-2762685-A1 (CA)
Title: Excrement-urine tray device and non-water washing device provided therewith in toilet
Inventor: WU HAO
IPC: E03D5/014
Filed: 2010-05-19
Abstract: An excrement-urine tray device (200, 300, 400) for separating excrement from urine includes an excrement-urine tray (210, 310, 410), a support device and a force moment generating device (220, 320, 420). The excrement-urine tray (210, 310, 410) comprises a flat plate (211, 311, 411), a baffle (212, 312, 412) extending upward and outward from whole or part edge of the flat plate (211, 311, 411), and an opening (213) or channels (313, 413) provided on a longitudinal side of the excrement-urine tray (210, 310, 410). The excrement-urine tray (210, 310, 410) is connected to the support device, and driven to overturn on the support device by the force moment produced by the force moment generating device (220, 320, 420). The force moment generating device (220, 320, 420) is provided on the excrement-urine tray (210, 310, 410) and between two supports (230, 330, 430) and the opening (213) or the channels (313, 413). A non-water washing device (100a, 100b, 100c, 100d) provided with the excrementurine tray device (200, 300, 400) in toilet is also provided.